logo transparent gif
top_white_spacer
Home Latest Stock Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Investor Insights Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Back
First   < Newer   3281-3300 of 10564   Older>   Last  
Latest Forum Topics / Riverstone    Last:0.87    -0.015  Post Reply
RIVERSTONE HOLDINGS LIMITED
sklong138
Elite
06-May-2021 20:38     
 
sklong138 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		https://youtu.be/XQX96MghwkM
 Useful To Me  Not Useful To Me
tonyja
Elite
06-May-2021 18:47     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Nope. Thailand sentiment so far no windtax as stgt provide job. ASP isn' t high, room for improvement. Dyodd

zandlery      ( Date: 06-May-2021 15:54) Posted:

Eventually STGT will join the trend as medical trend.
Fundamentally all medical companies reap good profit this few years but trend movement by BB will determine their direction.

tonyja      ( Date: 06-May-2021 15:49) Posted:

On this score, STGT   ia also a better SAFE HAVEN PLAY than Supermax besides STA
 Useful To Me  Not Useful To Me


zandlery
Supreme
06-May-2021 17:04     
 
zandlery About Contact  Quote this Post!   Mood: cool
  x 0
  x 0

 Alert Admin 		Not game over... It's game all over again.... 😅 .
If can wait.. Gotta wait if can wait again....... Just don't contra... Those contra previously when medical counter rising all get stop loss I think.

Twiggy      ( Date: 06-May-2021 16:18) Posted:

Game over

zandlery      ( Date: 06-May-2021 13:32) Posted:

Haizz... Whoever manipulated the price don't even hold it. Start all over again, next time I guess.
I think just have to wait till the nig volume shortist cover first.


 Useful To Me  Not Useful To Me
highlander
Senior
06-May-2021 16:50     
 
highlander About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Me too. Vested and have confidence of a good results. Info shared by Traveller consistent with the report by Tradeview.

sklong138      ( Date: 06-May-2021 12:04) Posted:

Agreed with your point 4. Will hold Riverstone till their announcement as anticipated on 10 May which is just next week. Cheers. Huat!!!

Traveler      ( Date: 06-May-2021 11:58) Posted:


I just like to provide my opinion on the glove price movement over the last few days and today. DYODD.
1. The selling of glove counters in Bursa today is due to the lower than expected profit of Supermax. Supermax used to sell a lot of glove on spot pricing (ridiculously high) when demand was tight. Now that demand is easing, spot pricing naturally drop faster.     
 
2. For  Hartalega, their share also dropped after they announced their result as the QoQ increase of 12% is below market expectation. The net profit is RM1.12B despite the low utilization of 64%. Reason for this is the Covid induced shutdown s and freight delays. Their glove ASP is still holding well.
 
3. Kossan' s share price trended upwards after they announced their better-than expected results of RM1 billion. Believe they also do not have much spot pricing sales. Besides that, they indicated very positive contribution from their cleanroom glove business. 
 
4. For  Riverstone, we all know of their strong  cleanroom glove business  and that  they do not have much  spot price sales. With such differentiation, I believe they will hold well.  Think they will announce the result on 10 May.
 


 Useful To Me  Not Useful To Me
Abe2021
Veteran
06-May-2021 16:42     
 
Abe2021 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Agreed with you 

zandlery      ( Date: 06-May-2021 15:54) Posted:

Eventually STGT will join the trend as medical trend.
Fundamentally all medical companies reap good profit this few years but trend movement by BB will determine their direction.

tonyja      ( Date: 06-May-2021 15:49) Posted:

On this score, STGT   ia also a better SAFE HAVEN PLAY than Supermax besides STA
 Useful To Me  Not Useful To Me


Twiggy
Member
06-May-2021 16:18     
 
Twiggy About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Game over

zandlery      ( Date: 06-May-2021 13:32) Posted:

Haizz... Whoever manipulated the price don't even hold it. Start all over again, next time I guess.
I think just have to wait till the nig volume shortist cover first.

 Useful To Me  Not Useful To Me
zandlery
Supreme
06-May-2021 15:54     
 
zandlery About Contact  Quote this Post!   Mood: cool
  x 0
  x 0

 Alert Admin 		Eventually STGT will join the trend as medical trend.
Fundamentally all medical companies reap good profit this few years but trend movement by BB will determine their direction.

tonyja      ( Date: 06-May-2021 15:49) Posted:

On this score, STGT   ia also a better SAFE HAVEN PLAY than Supermax besides STA.

tonyja      ( Date: 06-May-2021 15:44) Posted:



Tradeview Commentaries - Supermax DOES NOT Represent Hartalega, Riverstone or Kossan

 

Seeing the title, you may be wondering, Supermax is part of the Big 4, how can it not be a representation of the glove sector and other peers. Do have a little patience and read on. 

I believe Malaysia investors are the most savvy when it comes to the glove sector. Many know quite a lot about gloves, ASP, buying / selling trends, pros & cons. So all these need not require further explanation. The only 2 common issues I come across that most investors differ upon is their preference of the glove companies and the valuation. 

 

Ex: I noticed quite a clear distinction. Those who like to invest in Top Glove and Supermax generally do not invest in Hartalega and Kossan. Vice versa. The question is why? Well the most common reason I hear retail investors highlighting is that " ASP of Supermax is highest followed by Top Glove" , " Supermax and Top Glove share price always surge like rocket unlike Hartalega and Kossan" etc. A few prominent investors even use PER to justify, Supermax is the cheapest glove company amongst all. It is for this reason, retail investors seem to like Supermax and Top Glove more than the others. 

 

Now, this is where I would share a different perspective. I have always highlighted my favourite glove companies would be Hartalega and Riverstone. Sri Trang Agro and Kossan is close by. The main reason I like Hartalega and Riverstone is because of the high level of efficiency, productivity, ESG compliant and innovation / market leader in their respective area. I even called Hartalega, the " True King of Nitrile Glove" . Why? Because being a champion in the particular product or sector the metric to measure is not solely capacity. Biggest volume dont make you the king. Your quality, innovation and pioneering initiatives is what sets apart the Tier 1 from the others. If we sum up everything, it comes down to the management. When you invest in Berkshire Hathaway, I believe 90% of the investors invest because they believe in Warren Buffet & Charlie Munger, not because of the companies that Berkshire Hathaway owns. When local retail investors invest in Public Bank, they believe in Tan Sri Teh Hiong Piow. When you invest in Hartalega, you believe in the management of Mr Kuan & family to do the right thing. 

 

We know Supermax pride itself of being an OBM player. During the height of pandemic, they were first to hike ASP to sky high levels. At one point as high as USD 150-160 per carton (not blended ASP). Supermax reduced OEM, cut out middleman and distributors but go direct to end consumers or clients. Many praised Supermax and hence invested in them. Research houses said " OBM model paid off handsomely" . Shower of praises keep pouring in. What happened overnight? Why the negativity all around? 

 

Well, OBM is a double edge sword. Life is also a cycle. What goes around comes around. In times of need, hiking ASP astronomically and cutting out distributors allow the company to maximise profits. Similarly, when times are less dire, customers need not take at such exorbitant prices. However, as Supermax focused on spot rates, losing OEM clients with long term contracts, the impact starts to kick in and faster than their peers. 

 

Hartalega, Kossan & Riverstone had the foresight to be gentleman and considerate in taking care of their clients. They were slow to hike rates, they ensure all existing clients can secure allocations. Even spot rates did not take up large portion of their total capacity. They allowed distributors, middleman, OEM clients to make fat margins (sharing profits with them). If you are the client, who would you go to now if you want to buy your products? This is why Hartalega ASP is rising and in Supermax own statement " Spot rate prices have fallen below contract prices" . Supermax is not a representation of Hartalega, Kossan or Riverstone. It never was and never will be. The business model and management philosophy is different. Retail investors must distinguish fact from fiction.

 

Source : www.tradeview.my


 Useful To Me  Not Useful To Me
tonyja
Elite
06-May-2021 15:49     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		On this score, STGT   ia also a better SAFE HAVEN PLAY than Supermax besides STA.

tonyja      ( Date: 06-May-2021 15:44) Posted:



Tradeview Commentaries - Supermax DOES NOT Represent Hartalega, Riverstone or Kossan

 

Seeing the title, you may be wondering, Supermax is part of the Big 4, how can it not be a representation of the glove sector and other peers. Do have a little patience and read on. 

I believe Malaysia investors are the most savvy when it comes to the glove sector. Many know quite a lot about gloves, ASP, buying / selling trends, pros & cons. So all these need not require further explanation. The only 2 common issues I come across that most investors differ upon is their preference of the glove companies and the valuation. 

 

Ex: I noticed quite a clear distinction. Those who like to invest in Top Glove and Supermax generally do not invest in Hartalega and Kossan. Vice versa. The question is why? Well the most common reason I hear retail investors highlighting is that " ASP of Supermax is highest followed by Top Glove" , " Supermax and Top Glove share price always surge like rocket unlike Hartalega and Kossan" etc. A few prominent investors even use PER to justify, Supermax is the cheapest glove company amongst all. It is for this reason, retail investors seem to like Supermax and Top Glove more than the others. 

 

Now, this is where I would share a different perspective. I have always highlighted my favourite glove companies would be Hartalega and Riverstone. Sri Trang Agro and Kossan is close by. The main reason I like Hartalega and Riverstone is because of the high level of efficiency, productivity, ESG compliant and innovation / market leader in their respective area. I even called Hartalega, the " True King of Nitrile Glove" . Why? Because being a champion in the particular product or sector the metric to measure is not solely capacity. Biggest volume dont make you the king. Your quality, innovation and pioneering initiatives is what sets apart the Tier 1 from the others. If we sum up everything, it comes down to the management. When you invest in Berkshire Hathaway, I believe 90% of the investors invest because they believe in Warren Buffet & Charlie Munger, not because of the companies that Berkshire Hathaway owns. When local retail investors invest in Public Bank, they believe in Tan Sri Teh Hiong Piow. When you invest in Hartalega, you believe in the management of Mr Kuan & family to do the right thing. 

 

We know Supermax pride itself of being an OBM player. During the height of pandemic, they were first to hike ASP to sky high levels. At one point as high as USD 150-160 per carton (not blended ASP). Supermax reduced OEM, cut out middleman and distributors but go direct to end consumers or clients. Many praised Supermax and hence invested in them. Research houses said " OBM model paid off handsomely" . Shower of praises keep pouring in. What happened overnight? Why the negativity all around? 

 

Well, OBM is a double edge sword. Life is also a cycle. What goes around comes around. In times of need, hiking ASP astronomically and cutting out distributors allow the company to maximise profits. Similarly, when times are less dire, customers need not take at such exorbitant prices. However, as Supermax focused on spot rates, losing OEM clients with long term contracts, the impact starts to kick in and faster than their peers. 

 

Hartalega, Kossan & Riverstone had the foresight to be gentleman and considerate in taking care of their clients. They were slow to hike rates, they ensure all existing clients can secure allocations. Even spot rates did not take up large portion of their total capacity. They allowed distributors, middleman, OEM clients to make fat margins (sharing profits with them). If you are the client, who would you go to now if you want to buy your products? This is why Hartalega ASP is rising and in Supermax own statement " Spot rate prices have fallen below contract prices" . Supermax is not a representation of Hartalega, Kossan or Riverstone. It never was and never will be. The business model and management philosophy is different. Retail investors must distinguish fact from fiction.

 

Source : www.tradeview.my

 Useful To Me  Not Useful To Me


tonyja
Elite
06-May-2021 15:44     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Tradeview Commentaries - Supermax DOES NOT Represent Hartalega, Riverstone or Kossan

 

Seeing the title, you may be wondering, Supermax is part of the Big 4, how can it not be a representation of the glove sector and other peers. Do have a little patience and read on. 

I believe Malaysia investors are the most savvy when it comes to the glove sector. Many know quite a lot about gloves, ASP, buying / selling trends, pros & cons. So all these need not require further explanation. The only 2 common issues I come across that most investors differ upon is their preference of the glove companies and the valuation. 

 

Ex: I noticed quite a clear distinction. Those who like to invest in Top Glove and Supermax generally do not invest in Hartalega and Kossan. Vice versa. The question is why? Well the most common reason I hear retail investors highlighting is that " ASP of Supermax is highest followed by Top Glove" , " Supermax and Top Glove share price always surge like rocket unlike Hartalega and Kossan" etc. A few prominent investors even use PER to justify, Supermax is the cheapest glove company amongst all. It is for this reason, retail investors seem to like Supermax and Top Glove more than the others. 

 

Now, this is where I would share a different perspective. I have always highlighted my favourite glove companies would be Hartalega and Riverstone. Sri Trang Agro and Kossan is close by. The main reason I like Hartalega and Riverstone is because of the high level of efficiency, productivity, ESG compliant and innovation / market leader in their respective area. I even called Hartalega, the " True King of Nitrile Glove" . Why? Because being a champion in the particular product or sector the metric to measure is not solely capacity. Biggest volume dont make you the king. Your quality, innovation and pioneering initiatives is what sets apart the Tier 1 from the others. If we sum up everything, it comes down to the management. When you invest in Berkshire Hathaway, I believe 90% of the investors invest because they believe in Warren Buffet & Charlie Munger, not because of the companies that Berkshire Hathaway owns. When local retail investors invest in Public Bank, they believe in Tan Sri Teh Hiong Piow. When you invest in Hartalega, you believe in the management of Mr Kuan & family to do the right thing. 

 

We know Supermax pride itself of being an OBM player. During the height of pandemic, they were first to hike ASP to sky high levels. At one point as high as USD 150-160 per carton (not blended ASP). Supermax reduced OEM, cut out middleman and distributors but go direct to end consumers or clients. Many praised Supermax and hence invested in them. Research houses said " OBM model paid off handsomely" . Shower of praises keep pouring in. What happened overnight? Why the negativity all around? 

 

Well, OBM is a double edge sword. Life is also a cycle. What goes around comes around. In times of need, hiking ASP astronomically and cutting out distributors allow the company to maximise profits. Similarly, when times are less dire, customers need not take at such exorbitant prices. However, as Supermax focused on spot rates, losing OEM clients with long term contracts, the impact starts to kick in and faster than their peers. 

 

Hartalega, Kossan & Riverstone had the foresight to be gentleman and considerate in taking care of their clients. They were slow to hike rates, they ensure all existing clients can secure allocations. Even spot rates did not take up large portion of their total capacity. They allowed distributors, middleman, OEM clients to make fat margins (sharing profits with them). If you are the client, who would you go to now if you want to buy your products? This is why Hartalega ASP is rising and in Supermax own statement " Spot rate prices have fallen below contract prices" . Supermax is not a representation of Hartalega, Kossan or Riverstone. It never was and never will be. The business model and management philosophy is different. Retail investors must distinguish fact from fiction.

 

Source : www.tradeview.my
 Useful To Me  Not Useful To Me
tonyja
Elite
06-May-2021 14:20     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Relative to Msian Gloves Counters, STA is   considered a SAFE HAVEN HYBRID STOCK as STA is both RUBBER/GLOes PLAY all in one.
However DUE DILIGENCE IS SERIOUSLY WARRANTED 

tonyja      ( Date: 06-May-2021 09:24) Posted:

Supermax: Rubber glove spot prices on downtrend, fall 15% to 25%

/ 
May 05, 2021 19:20 pm +08
Supermax: Rubber glove spot prices on downtrend, fall 15% to 25%
KUALA LUMPUR (May 5): As more new capacities are available in the market, rubber glove prices have started falling, said Supermax Corp Bhd.

" The glove prices have since dropped by between 15% and 25%. Currently, the spot market prices are lower than the contracted prices," said the rubber glove maker in its quarterly results' announcement.

The group, which posted a net profit of RM1 billion for the third quarter ended March 31, 2021 (3QFY21), said it anticipates the competition to intensify going forward.

There have been more new glove players jumping on the bandwagon in view of the surge in demand. In addition, the current players are increasing capacities in a large scale, especially players who are public-listed companies based in China, Malaysia and Thailand, Supermax commented.

" We are confident that our sound business model and well-established distribution networks built up since 1989 have prepared us well for all challenges ahead," it said.

On prospects, the group said the demand for gloves as personal protective equipment remains strong as the world continues to fight the Covid-19 pandemic.

While it is widely expected that the roll-out of Covid-19 vaccines will cause glove demand and consumption to moderate, the company believes that the drop will likely be gradual due to the structural changes in consumption, such as new consumption, new customers and greatly heightened healthcare and hygiene awareness.

Supermax announced a quarterly net profit of RM1 billion for 3QFY21, 5.2% lower compared with RM1.06 billion recorded in 2QFY21. Its quarter revenue fell 3% to RM1.94 billion in 3QFY21 compared with RM2 billion in 2QFY21.

Supermax commented its earnings would have been even better if not for the temporary shutdown of its Meru plants for sanitisation following detection of positive Covid-19 cases among the foreign workers.

According to Supermax, the group currently exports 58% of production under its own brands via its own distribution centres and 40% through independent distributors the remaining 2% is for original equipment manufacturer (OEM) production.

" Due to the current robust demand, we are taking the opportunity to build new relationships with new customers and distributors in anticipation that they will continue with repeat orders post pandemic," it said.
 Useful To Me  Not Useful To Me
zandlery
Supreme
06-May-2021 13:32     
 
zandlery About Contact  Quote this Post!   Mood: cool
  x 0
  x 0

 Alert Admin 		Haizz... Whoever manipulated the price don't even hold it. Start all over again, next time I guess.
I think just have to wait till the nig volume shortist cover first.
 Useful To Me  Not Useful To Me
sklong138
Elite
06-May-2021 12:04     
 
sklong138 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Agreed with your point 4. Will hold Riverstone till their announcement as anticipated on 10 May which is just next week. Cheers. Huat!!!

Traveler      ( Date: 06-May-2021 11:58) Posted:


I just like to provide my opinion on the glove price movement over the last few days and today. DYODD.
1. The selling of glove counters in Bursa today is due to the lower than expected profit of Supermax. Supermax used to sell a lot of glove on spot pricing (ridiculously high) when demand was tight. Now that demand is easing, spot pricing naturally drop faster.     
 
2. For  Hartalega, their share also dropped after they announced their result as the QoQ increase of 12% is below market expectation. The net profit is RM1.12B despite the low utilization of 64%. Reason for this is the Covid induced shutdown s and freight delays. Their glove ASP is still holding well.
 
3. Kossan' s share price trended upwards after they announced their better-than expected results of RM1 billion. Believe they also do not have much spot pricing sales. Besides that, they indicated very positive contribution from their cleanroom glove business. 
 
4. For  Riverstone, we all know of their strong  cleanroom glove business  and that  they do not have much  spot price sales. With such differentiation, I believe they will hold well.  Think they will announce the result on 10 May.
 


Jasongan      ( Date: 06-May-2021 09:33) Posted:

Meanwhile kossan XD still so strong...riverstone really jialat.same cleanroom glove
 Useful To Me  Not Useful To Me


Traveler
Member
06-May-2021 11:58     
 
Traveler About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin
I just like to provide my opinion on the glove price movement over the last few days and today. DYODD.
1. The selling of glove counters in Bursa today is due to the lower than expected profit of Supermax. Supermax used to sell a lot of glove on spot pricing (ridiculously high) when demand was tight. Now that demand is easing, spot pricing naturally drop faster.     
 
2. For  Hartalega, their share also dropped after they announced their result as the QoQ increase of 12% is below market expectation. The net profit is RM1.12B despite the low utilization of 64%. Reason for this is the Covid induced shutdown s and freight delays. Their glove ASP is still holding well.
 
3. Kossan' s share price trended upwards after they announced their better-than expected results of RM1 billion. Believe they also do not have much spot pricing sales. Besides that, they indicated very positive contribution from their cleanroom glove business. 
 
4. For  Riverstone, we all know of their strong  cleanroom glove business  and that  they do not have much  spot price sales. With such differentiation, I believe they will hold well.  Think they will announce the result on 10 May.
 


Jasongan      ( Date: 06-May-2021 09:33) Posted:

Meanwhile kossan XD still so strong...riverstone really jialat.same cleanroom glove
 Useful To Me  Not Useful To Me
Jasongan
Member
06-May-2021 09:33     
 
Jasongan About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Meanwhile kossan XD still so strong...riverstone really jialat.same cleanroom glove
 Useful To Me  Not Useful To Me
tonyja
Elite
06-May-2021 09:31     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

Moderna booster increases antibodies against COVID-19 variants, early data shows

06 May 2021 05:22AM
World
FILE PHOTO: Vial and sryinge are seen in front of displayed Moderna logo
A vial and syringe are seen in front of a displayed Moderna logo in this illustration taken Jan  11, 2021. (Photo: REUTERS/Dado Ruvic)
(Updated:  06 May 2021 06:52AM)

Bookmark



NEW YORK: Moderna said on Wednesday (May 5) early human trial data shows that a third dose of either its current COVID-19 shot or an experimental new vaccine candidate increases immunity against variants of COVID-19 first found in Brazil and South Africa.

The booster shots, given to volunteers previously inoculated with Moderna' s two-dose vaccine regimen, also boosted antibodies against the original version of COVID-19, Moderna said.

The early data comes from a 40-person trial testing both Moderna' s existing shot and a version developed to protect against the South African variant of COVID-19 called mRNA-1273.351. Moderna is also studying a shot that combines both the new and existing vaccine.

READ:  WHO lists Moderna' s COVID-19 vaccine for emergency use

READ:  US preparing for 1-year COVID-19 booster shots Pfizer chief sees need



The results show that while booster shots of either version of the vaccine increased antibodies against all of the variants of COVID-19 tested in the trial, the new booster had a bigger response against the South African variant than the original vaccine.

" We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective" against the newer variants of COVID-19, Stephane Bancel, Moderna' s chief executive officer, said in a statement.

Both booster shots were well tolerated, with side effects similar to what volunteers in previous studies experienced from the second dose of its vaccine, Moderna said.

The new variants of COVID-19 first discovered in South Africa and Brazil are thought to be more resistant to existing vaccines. Both variants have been detected in the United States but comprise only a small fraction of US  cases so far, according to federal data last updated in April.

Moderna' s study is looking at levels of antibodies in participants' blood that combat COVID-19, an early indication that they will be protected against the virus. It first announced it was studying ways to protect against the variants of COVID-19 in February.

Moderna expects to share additional data soon on another potential booster shot that mixes its existing COVID-19 vaccine with the newly developed shot.

The US  government scientists at the National Institute of Allergy and Infectious Diseases (NIAID) is conducting a separate early stage study of mRNA-1273.351, Moderna said. 
 Useful To Me  Not Useful To Me
tonyja
Elite
06-May-2021 09:24     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Supermax: Rubber glove spot prices on downtrend, fall 15% to 25%

/ 
May 05, 2021 19:20 pm +08
Supermax: Rubber glove spot prices on downtrend, fall 15% to 25%
KUALA LUMPUR (May 5): As more new capacities are available in the market, rubber glove prices have started falling, said Supermax Corp Bhd.

" The glove prices have since dropped by between 15% and 25%. Currently, the spot market prices are lower than the contracted prices," said the rubber glove maker in its quarterly results' announcement.

The group, which posted a net profit of RM1 billion for the third quarter ended March 31, 2021 (3QFY21), said it anticipates the competition to intensify going forward.

There have been more new glove players jumping on the bandwagon in view of the surge in demand. In addition, the current players are increasing capacities in a large scale, especially players who are public-listed companies based in China, Malaysia and Thailand, Supermax commented.

" We are confident that our sound business model and well-established distribution networks built up since 1989 have prepared us well for all challenges ahead," it said.

On prospects, the group said the demand for gloves as personal protective equipment remains strong as the world continues to fight the Covid-19 pandemic.

While it is widely expected that the roll-out of Covid-19 vaccines will cause glove demand and consumption to moderate, the company believes that the drop will likely be gradual due to the structural changes in consumption, such as new consumption, new customers and greatly heightened healthcare and hygiene awareness.

Supermax announced a quarterly net profit of RM1 billion for 3QFY21, 5.2% lower compared with RM1.06 billion recorded in 2QFY21. Its quarter revenue fell 3% to RM1.94 billion in 3QFY21 compared with RM2 billion in 2QFY21.

Supermax commented its earnings would have been even better if not for the temporary shutdown of its Meru plants for sanitisation following detection of positive Covid-19 cases among the foreign workers.

According to Supermax, the group currently exports 58% of production under its own brands via its own distribution centres and 40% through independent distributors the remaining 2% is for original equipment manufacturer (OEM) production.

" Due to the current robust demand, we are taking the opportunity to build new relationships with new customers and distributors in anticipation that they will continue with repeat orders post pandemic," it said.
 Useful To Me  Not Useful To Me
tonyja
Elite
05-May-2021 20:17     
 
tonyja About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

US Customs seizes Malaysia' s Top Glove shipment following forced labour finding

05 May 2021 09:01AM
World
The United States has imposed a ban on Malaysian glove maker Top Glove after concluding the company
The United States has imposed a ban on Malaysian glove maker Top Glove after concluding the company uses forced labour. (Photo:AFP/Mohd Rasfan)
(Updated:  05 May 2021 09:10AM)

Bookmark



KUALA LUMPUR: The US  Customs and Border Protection (CBP) has seized a shipment of 3.97 million nitrile disposable gloves from Malaysia' s Top Glove estimated to be worth US$518,000, on indications they were made by forced labour, it said on  Wednesday (May 5).

CBP on Mar 29 issued a forced labour finding based on evidence of multiple forced labour indicators in the world' s largest medical glove maker' s production process.

It had initially banned products from two of Top Glove' s subsidiaries last July, but extended the ban to all of the manufacturer' s products made in Malaysia in March.

The indicators included debt bondage, excessive overtime, abusive working and living conditions, and retention of identity documents, the CBP said in a statement.

READ:  US Customs determines forced labour at Malaysia' s Top Glove, to seize gloves



The agency then directed personnel at all US  ports of entry to begin seizing disposable gloves produced in Malaysia by the glove maker.

" CBP continues to facilitate the importation of legitimate PPE needed for the COVID-19 pandemic while ensuring that the PPE is authorized and safe for use," Diann Rodriguez, Area Port Director-Cleveland, referring to personal protective equipment.

Top Glove said last month its glove production has been affected because of the US  ban, and announced last week it had resolved all indicators of forced labour in its operations, citing a report by the ethical trade consultancy it hired. 
 Useful To Me  Not Useful To Me
anton1967
Senior
05-May-2021 18:44     
 
anton1967 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Today Short qty : 120, 700 @1.3833
 Useful To Me  Not Useful To Me
anton1967
Senior
05-May-2021 16:12     
 
anton1967 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Yesterday shorted  232k @1.409 . Today is also a day for the shortists to enjoy !
 Useful To Me  Not Useful To Me
anton1967
Senior
05-May-2021 15:46     
 
anton1967 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		People who are vaccinated are more confident , but the virus has proven them wrong through infection !

crystalbee      ( Date: 05-May-2021 15:01) Posted:

I just sort of agree with PhilipTan about pre Covid and post Covid demand for gloves. I did not say masks and gloves not in demand. Just adding there is need to consider higher supply into market for honest picture. On vaccine efficacy, the vaccine makers themselves dare not boast of 100% so cases of re-infections still possible right? Have vaccine better than no vaccine no matter what. Precaution is very important too. 

 Useful To Me  Not Useful To Me
                                                         First   < Newer   3281-3300 of 10564   Older>   Last  



ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.